Patients with type 2 diabetes (T2D) who received glucagon-like peptide 1 (GLP-1) receptor agonists had a significantly lower risk of developing local or systemic complications — even if they developed ...
The product information for GLP-1s in the UK will now include warnings over their potential links to acute pancreatitis, regulators have announced. GLP-1s have been linked to a number of side effects, ...
Researchers found that the rate of pancreatitis was similar for those on vs not on a GLP-1 RA (2.5 vs 2.6%). For patients with severe triglyceride levels. HealthDay News — For adults with type 2 ...
In a candid revelation, actress Mayim Bialik opened up about her distressing journey with GLP-1 medication, which brought on ...
Add Yahoo as a preferred source to see more of our stories on Google. Health officials in the UK are launching an investigation into weight loss drugs after hundreds of consumers reported pancreas ...
LAS VEGAS — Off-label use of GLP-1 drugs by people with type 1 diabetes (T1D) did not lead to diabetic ketoacidosis (DKA) or pancreatitis in a large 1-year single-center study. Moreover, GLP-1 agonist ...
In a major new study, researchers from Intermountain Health in Salt Lake City have found that weight loss drugs used by patients who have high triglycerides do not increase their risk of pancreatitis ...
A real-world study of chronic pancreatitis found GLP-1 agonists to be associated with less pain medication use and lower risks for pancreatic interventions, including major surgery. (Gastro Hep ...
Mayim Bialik is sharing her "nightmare" experience on a GLP-1 medication. In a piece published in The Free Press on June 5, titled "Mayim Bialik: My GLP-1 Nightmare," the "Big Bang Theory" star and ...
Study also revealed no increased risk for major adverse cardiovascular events for patients on a GLP-1 RA versus those not on a GLP-1 RA. (HealthDay News) — For adults with type 2 diabetes and/or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results